How Prevalent is Macular Telangiectasia Type 2?

ISSN： 0928-6586

Source： Ophthalmic Epidemiology, Vol.19, Iss.4, 2012-08, pp. : 183-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unusual Presentations of Type 2 Idiopathic Macular Telangiectasia

Ophthalmologica, Vol. 230, Iss. 3, 2013-08 ,pp. : 126-130

Karger

Access to resources Recommend Favorite

Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia

Ophthalmic Research, Vol. 49, Iss. 4, 2013-01 ,pp. : 205-208

Karger

Access to resources Recommend Favorite

The Prevalence of Type 2 Idiopathic Macular Telangiectasia in Two African Populations

By Sallo Ferenc B. Leung Irene Mathenge Wanjiku Kyari Fatima Kuper Hannah Gilbert Clare E. Bird Alan C. Peto Tunde

Ophthalmic Epidemiology, Vol. 19, Iss. 4, 2012-08 ,pp. : 185-189

Informa Healthcare

Access to resources Recommend Favorite

Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3

By Clemons Traci E.

Ophthalmic Epidemiology, Vol. 20, Iss. 2, 2013-04 ,pp. : 109-113

Informa Healthcare

Access to resources Recommend Favorite

Reduced-Fluence Photodynamic Therapy Combined with Ranibizumab for Nonproliferative Macular Telangiectasia Type 2

Ophthalmologica, Vol. 229, Iss. 4, 2013-04 ,pp. : 195-202

Karger

Access to resources Recommend Favorite